These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 8276064

  • 1. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE, Berg M, Meyerson BJ.
    Eur J Pharmacol; 1993 Oct 19; 243(2):149-54. PubMed ID: 8276064
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 19; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Uphouse L, Andrade M, Caldarola-Pastuszka M, Maswood S.
    Pharmacol Biochem Behav; 1994 Mar 19; 47(3):467-70. PubMed ID: 8208763
    [Abstract] [Full Text] [Related]

  • 4. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y, Kitagawa K, Fujitani Y, Shibata K, Araki H, Sendou T, Gomita Y.
    Biol Pharm Bull; 2007 Jan 19; 30(1):117-20. PubMed ID: 17202670
    [Abstract] [Full Text] [Related]

  • 5. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):77-90. PubMed ID: 7813581
    [Abstract] [Full Text] [Related]

  • 6. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C, Mørk A.
    Eur Neuropsychopharmacol; 1999 Jun 01; 9(4):287-94. PubMed ID: 10422888
    [Abstract] [Full Text] [Related]

  • 7. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells.
    Calogero AE, Bagdy G, Moncada ML, D'Agata R.
    J Endocrinol; 1993 Mar 01; 136(3):381-7. PubMed ID: 8386213
    [Abstract] [Full Text] [Related]

  • 8. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N, Friedman E.
    Eur J Pharmacol; 1996 Jun 27; 307(2):211-7. PubMed ID: 8832223
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G, Kalogeras KT.
    Brain Res; 1993 May 21; 611(2):330-2. PubMed ID: 8334526
    [Abstract] [Full Text] [Related]

  • 10. Neonatal organizational effects of the 5-HT2 and 5-HT1A subsystems on adult behavior in the rat.
    González MI, Albonetti E, Siddiqui A, Farabollini F, Wilson CA.
    Pharmacol Biochem Behav; 1996 May 21; 54(1):195-203. PubMed ID: 8728558
    [Abstract] [Full Text] [Related]

  • 11. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
    Ruotsalainen S, MacDonald E, Koivisto E, Stefanski R, Haapalinna A, Riekkinen P, Sirviö J.
    J Psychopharmacol; 1998 May 21; 12(2):177-85. PubMed ID: 9694031
    [Abstract] [Full Text] [Related]

  • 12. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
    Krebs KM, Geyer MA.
    Psychopharmacology (Berl); 1994 Jan 21; 113(3-4):429-37. PubMed ID: 7862855
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological profile of (-)HT-90B, a novel 5-HT1A receptor agonist/5-HT2 receptor antagonist.
    Uchida H, Inagawa K, Tameda C, Miyauchi T.
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov 21; 19(7):1201-16. PubMed ID: 8787043
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH, Broekkamp CL.
    Psychopharmacology (Berl); 1991 Nov 21; 105(2):219-24. PubMed ID: 1839064
    [Abstract] [Full Text] [Related]

  • 15. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
    Maura G, Barzizza A, Folghera S, Raiteri M.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar 21; 343(3):229-36. PubMed ID: 1830929
    [Abstract] [Full Text] [Related]

  • 16. Serotonin receptor ontogeny: effects of agonists in 1-day-old rats.
    Pranzatelli MR.
    Pharmacol Biochem Behav; 1992 Dec 21; 43(4):1273-7. PubMed ID: 1475312
    [Abstract] [Full Text] [Related]

  • 17. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats.
    Wada Y, Shiraishi J, Nakamura M, Koshino Y.
    Brain Res; 1997 Feb 07; 747(2):338-42. PubMed ID: 9046012
    [Abstract] [Full Text] [Related]

  • 18. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats.
    Hasegawa Y, Ono H.
    Brain Res; 1996 Oct 28; 738(1):158-61. PubMed ID: 8949941
    [Abstract] [Full Text] [Related]

  • 19. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 28; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 20. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U, Merico A, Ermani M, Ori C.
    Brain Res; 2010 Jun 04; 1335():24-34. PubMed ID: 20381465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.